The PI3K/Akt Signaling Pathway Mediates the High Glucose-Induced Expression of Extracellular Matrix Molecules in Human Retinal Pigment Epithelial Cells

Journal of Diabetes Research

Volumn 2015, Issue , 2015, Pages

  Qin, Dong ^a,b,c   Zhang, Guo Ming ^b   Xu, Xun ^c   Wang, Li Ya ^a  

^a Henan Eye Institute   (China)

^b SHENZHEN EYE HOSPITAL   (China)

^c SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; COLLAGEN TYPE 4; FIBRONECTIN; GLUCOSE; LAMININ; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B;

ARTICLE; ENZYME PHOSPHORYLATION; EPITHELIUM CELL; EXTRACELLULAR MATRIX; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA PIGMENT CELL; CYTOLOGY; FLUORESCENCE MICROSCOPY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; METABOLISM; POLYMERASE CHAIN REACTION; RETINAL PIGMENT EPITHELIUM; RISK FACTOR; SIGNAL TRANSDUCTION;

COLLAGEN TYPE IV; EXTRACELLULAR MATRIX; FIBRONECTINS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GLUCOSE; HUMANS; LAMININ; MICROSCOPY, FLUORESCENCE; PHOSPHATIDYLINOSITOL 3-KINASES; POLYMERASE CHAIN REACTION; RETINAL PIGMENT EPITHELIUM; RISK FACTORS; SIGNAL TRANSDUCTION;

EID: 84937232158     PISSN: 23146745     EISSN: 23146753     Source Type: Journal    
DOI: 10.1155/2015/920280     Document Type: Article

References (29)

1. N. Cheung, P. Mitchell, and T. Y. Wong, "Diabetic retinopathy," The Lancet, vol. 376, no. 9735, pp. 124-136, 2010.
2. S. Roy, T. Sato, G. Paryani, and R. Kao, "Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats," Diabetes, vol. 52, no. 5, pp. 1229-1234, 2003.
3. P. A. Campochiaro, "Pathogenic mechanisms in proliferative vitreoretinopathy," Archives of Ophthalmology, vol. 115, no. 2, pp. 237-241, 1997.
4. P. Esser, K. Heimann, K.-U. Bartz-Schmidt et al., "Apoptosis in proliferative vitreoretinal disorders: possible involvement of TGF-β-induced RPE cell apoptosis," Experimental Eye Research, vol. 65, no. 3, pp. 365-378, 1997.
5. H. Miller, B. Miller, and S. J. Ryan, "The role of retinal pigment epithelium in the involution of subretinal neovascularization," Investigative Ophthalmology & Visual Science, vol. 27, no. 11, pp. 1644-1652, 1986.
6. C. W. Hamilton, D. Chandler, G. K. Klintworth, and R. Machemer, "A transmission and scanning electron microscopic study of surgically excised preretinal membrane proliferations in diabetes mellitus," American Journal of Ophthalmology, vol. 94, no. 4, pp. 473-488, 1982.
7. D. R. J. Snead, S. James, andM. P. Snead, "Pathological changes in the vitreoretinal junction 1: epiretinal membrane formation," Eye, vol. 22, no. 10, pp. 1310-1317, 2008.
8. A. G. Bader, S. Kang, L. Zhao, and P. K. Vogt, "Oncogenic PI3K deregulates transcription and translation," Nature Reviews Cancer, vol. 5, no. 12, pp. 921-929, 2005.
9. M. Graupera, J. Guillermet-Guibert, L. C. Foukas et al., "Angiogenesis selectively requires the p110α isoformof PI3K to control endothelial cell migration," Nature, vol. 453, no. 7195, pp. 662-666, 2008.
10. H. Cho, J. Mu, J. K. Kim et al., "Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKBβ)," Science, vol. 292, no. 5522, pp. 1728-1731, 2001.
11. D. Qin, X.-X. Zheng, and Y.-R. Jiang, "Apelin-13 induces proliferation, migration, and collagen I mRNA expression in human RPE cells via PI3K/Akt and MEK/Erk signaling pathways," Molecular Vision, vol. 19, pp. 2227-2236, 2013.
12. G. Forte, M. Minieri, P. Cossa et al., "Hepatocyte growth factor effects on mesenchymal stem cells: proliferation, migration, and differentiation," Stem Cells, vol. 24, no. 1, pp. 23-33, 2006.
13. J. A. Engelman, "Targeting PI3K signalling in cancer: opportunities, challenges and limitations," Nature Reviews Cancer, vol. 9, no. 8, pp. 550-562, 2009.
14. H. A. Burris III, "Overcoming acquired resistance to anticancer therapy: focus on the PI3K/AKT/mTOR pathway," Cancer Chemotherapy and Pharmacology, vol. 71, no. 4, pp. 829-842, 2013.
15. X. M. Wang, M. Yao, S. X. Liu, J. Hao, Q. J. Liu, and F. Gao, "Interplay between the Notch and PI3K/Akt pathways in high glucose-induced podocyte apoptosis," The American Journal of Physiology-Renal Physiology, vol. 306, no. 2, pp. F205-F213, 2014.
16. D. K. Montes, M. Brenet, V. C. Muñoz et al., "Vasopressin activates Akt/mTOR pathway in smooth muscle cells cultured in high glucoe concentration," Biochemical and Biophysical Research Communications, vol. 441, no. 4, pp. 923-928, 2013.
17. G. Guan, H. Han, Y. Yang,Y. Jin,X. Wang, andX. Liu, "Neferine prevented hyperglycemia-induced endothelial cell apoptosis through suppressing ROS/Akt/NF-κB signal," Endocrine, vol. 47, no. 3, pp. 764-771, 2014.
18. Y. Cheng, D. Diao, H. Zhang et al., "High glucose-induced resistance to 5-fluorouracil in pancreatic cancer cells alleviated by 2-deoxy-D-glucose," Biomedical Reports, vol. 2, no. 2, pp. 188-192, 2014.
19. Y. Liu,W. Li, H. Liu et al., "Inhibition effect of small interfering RNA of connective tissue growth factor on the expression of extracellular matrix molecules in cultured human renal proximal tubular cells," Renal Failure, vol. 36,no. 2, pp. 278-284, 2014.
20. R. Xie, X. Li, Y. Ling et al., "Alpha-lipoic acid pre- and post-treatments provide protection against in vitro ischemiareperfusion injury in cerebral endothelial cells via Akt/mTOR signaling," Brain Research, vol. 1482, pp. 81-90, 2012.
21. Y. Wang, X. Li, Y. Guo, L. Chan, and X. Guan, "α-lipoic acid increases energy expenditure by enhancing adenosine monophosphate- activated protein kinase-peroxisome proliferatoractivated receptor-γ coactivator-1α signaling in the skeletal muscle of aged mice," Metabolism, vol. 59, no. 7, pp. 967-976, 2010.
22. F. J. Bohanon, X. Wang, C. Ding et al., "Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis," Journal of Surgical Research, vol. 190, no. 1, pp. 55-63, 2014.
23. T. Moriya, T. J. Groppoli, Y. Kim, and M. Mauer, "Quantitative immunoelectron microscopy of type VI collagen in glomeruli in type I diabetic patients," Kidney International, vol. 59, no. 1, pp. 317-323, 2001.
24. M. S. Razzaque, T. Koji, T. Harada, and T. Taguchi, "Identification of type VI collagen synthesizing cells in human diabetic glomerulosclerosis using renal biopsy sections," Analytical Cellular Pathology, vol. 15, no. 3, pp. 175-181, 1997.
25. T. Lan,T. Wu,C. Chen et al., "Berberine attenuates high glucoseinduced proliferation and extracellular matrix accumulation in mesangial cells: involvement of suppression of cell cycle progression and NF-κB/AP-1 pathways,"Molecular and Cellular Endocrinology, vol. 384, no. 1-2, pp. 109-116, 2014.
26. E. Ioachim, M. Stefaniotou, S. Gorezis, E. Tsanou, K. Psilas, and N. J. Agnantis, "Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy," European Journal of Ophthalmology, vol. 15, no. 3, pp. 384-391, 2005.
27. T. L. Phung, K. Ziv, D. Dabydeen et al., "Pathological angiogenesis is induced by sustained Akt signaling and inhibited by rapamycin," Cancer Cell, vol. 10, no. 2, pp. 159-170, 2006.
28. J. Karar and A. Maity, "PI3K/AKT/mTOR pathway in angiogenesis," Frontiers in Molecular Neuroscience, vol. 4, p. 51, 2011.
29. J. Polivka Jr. and F. Janku, "Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway," Pharmacology and Therapeutics, vol. 142, no. 2, pp. 164-175, 2014.